Witryna7 kwi 2024 · Impact Factor: 5.855 5-Year Impact Factor: 5.956 JOURNAL HOMEPAGE SUBMIT PAPER Multiple Sclerosis Journal is a peer-reviewed international journal that focuses on all aspects of multiple sclerosis, neuromyelitis optica and other … Neurorehabilitation & Neural Repair (NNR) offers innovative and reliable reports … Clinical EEG and Neuroscience conveys clinically relevant research and … Impact Factor: 6.312. Ranking: Clinical Neurology 28 out of 208 ... Multiple … Journal of Geriatric Psychiatry and Neurology (JGP) brings together original … Impact Factor. 5-Year Impact Factor 6.403. Journal Indexing & Metrics » Journal … WitrynaCiteScore: 3.7 ISSN: 1537-2073 Multidisciplinary Peer-Reviewed Open-Access The International Journal of MS Care is the official peer-reviewed publication of the …
Multiple Sclerosis Journal - Experimental, Translational …
Witryna12 kwi 2024 · Background: The anti-CD20 monoclonal antibody ocrelizumab has been widely employed in the treatment of people with multiple sclerosis (pwMS). However, its B-cell-depleting effect may induce a higher risk of infectious events and alterations in the secretion of B-cell-activating factors, such as BAFF, APRIL and CD40L. Methods: … Witryna7 kwi 2024 · Journal metrics Editorial board. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is dedicated to the research of motor neuron diseases, especially ALS (Lou Gehrig’s disease) and cognitive decline associated with frontotemporal degeneration. Amyotrophic Lateral Sclerosis and Frontotemporal … blinding light astd
Manuscript Submission Guidelines: Multiple Sclerosis …
Witryna23 mar 2024 · Objectives Previous studies suggested a higher rate of COVID-19 infection in patients with multiple sclerosis than in the general population, and limited studies addressed the impact of COVID-19 and its vaccination in patients with multiple sclerosis in Iran. We decided to investigate the factors associated with COVID-19 … Witryna11 lis 2024 · The Global Burden of Disease (GBD) 2016 Multiple Sclerosis Collaborators similarly reported that the prevalence of MS had risen between 1990 and 2016, estimating that there were 2,221,188 (95% Uncertainty Interval 2,033,866–2,436,858) persons living with MS in 2016. 10 The GBD group relied on … WitrynaThis result was also confirmed by a validation analysis to exclude impact of variable factors, such as disease duration and Expanded Disability Status Scale scores. Conclusions . ... “Correlation between interferon production and clinical disease activity in patients with multiple sclerosis,” Journal of Clinical Immunology, vol. 17, pp. 293 ... fredericks restaurant warrensville heights oh